HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katarzyna Kieć-Kononowicz Selected Research

Adenosine A2B Receptor

11/2022Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice.
3/2021PSB 603 - a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katarzyna Kieć-Kononowicz Research Topics

Disease

12Alzheimer Disease (Alzheimer's Disease)
08/2023 - 12/2013
10Obesity
04/2023 - 10/2016
10Epilepsy (Aura)
01/2021 - 09/2013
9Inflammation (Inflammations)
03/2024 - 01/2015
9Pain (Aches)
10/2023 - 01/2013
8Body Weight (Weight, Body)
11/2022 - 01/2018
7Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023 - 01/2008
6Neuralgia (Stump Neuralgia)
03/2024 - 10/2017
6Memory Disorders (Memory Loss)
08/2023 - 01/2017
6Seizures (Absence Seizure)
10/2018 - 09/2011
5Asthma (Bronchial Asthma)
03/2024 - 01/2013
5Pruritus (Itching)
10/2023 - 01/2013
5Cognitive Dysfunction
03/2020 - 01/2018
4Weight Gain
04/2023 - 01/2018
4Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2008
4Edema (Dropsy)
03/2021 - 08/2014
4Neoplasms (Cancer)
01/2021 - 01/2016
4Autistic Disorder (Autism)
06/2020 - 01/2018
3Amnesia (Dissociative Amnesia)
08/2023 - 01/2019
3Neuroinflammatory Diseases
02/2023 - 10/2019
3Lymphoma (Lymphomas)
01/2021 - 01/2016
3Neuroblastoma
05/2020 - 01/2014
2Peritonitis
03/2024 - 01/2017
2Central Nervous System Diseases (CNS Diseases)
03/2023 - 12/2019
2Colitis
01/2021 - 01/2021
2Catalepsy
05/2020 - 01/2015
2Schizophrenia (Dementia Praecox)
01/2020 - 10/2019
2Narcolepsy
01/2020 - 10/2019
2Leukemia
11/2017 - 01/2016
2Hypersensitivity (Allergy)
01/2015 - 01/2013
2Cardiac Arrhythmias (Arrythmia)
04/2012 - 12/2004
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2024
1Placenta Diseases (Placenta Disorder)
03/2024
1Pneumonia (Pneumonitis)
03/2024
1Periodontitis
03/2024
1Brain Injuries (Brain Injury)
03/2024
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
03/2024
1Infarction (Infarctions)
08/2023
1Stroke (Strokes)
08/2023
1Atherosclerosis
08/2023
1Feeding and Eating Disorders (Eating Disorder)
05/2023
1Immune System Diseases (Immune Disorders)
05/2023

Drug/Important Bio-Agent (IBA)

32LigandsIBA
03/2024 - 01/2013
26Histamine H3 Receptors (Histamine H3 Receptor)IBA
08/2023 - 09/2013
15Histamine (Histamine Dihydrochloride)FDA Link
10/2023 - 09/2010
7CarrageenanIBA
09/2023 - 08/2014
7Histamine H4 ReceptorsIBA
05/2023 - 01/2015
7Analgesics (Analgesic Drugs)IBA
05/2023 - 01/2017
6Neurotransmitter Agents (Neurotransmitter)IBA
08/2023 - 01/2018
6Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2018
5Dizocilpine Maleate (Dizocilpine)IBA
12/2020 - 01/2017
5Anticonvulsants (Antiepileptic Drugs)IBA
03/2020 - 09/2011
5Phenytoin (Dilantin)FDA LinkGeneric
11/2017 - 09/2013
4Formaldehyde (Formol)FDA Link
09/2023 - 10/2017
4Dopamine (Intropin)FDA LinkGeneric
01/2023 - 01/2015
4Monoamine Oxidase (MAO)IBA
07/2022 - 01/2020
4EsterasesIBA
06/2020 - 10/2019
4Acetylcholine (Acetylcholine Chloride)FDA Link
06/2020 - 10/2019
4Pentylenetetrazole (Metrazol)IBA
03/2020 - 07/2015
4pitolisantIBA
01/2020 - 06/2014
3EnzymesIBA
07/2022 - 01/2020
3Scopolamine (Hyoscine)FDA Link
06/2021 - 01/2017
3Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2021 - 12/2013
3Valproic Acid (Depakote)FDA LinkGeneric
06/2020 - 01/2018
3Neuroprotective AgentsIBA
05/2020 - 11/2019
3HydantoinsIBA
12/2019 - 01/2016
3imidazoleIBA
01/2019 - 09/2013
2XanthineIBA
08/2023 - 01/2023
2Proteins (Proteins, Gene)FDA Link
08/2023 - 11/2020
2sigma-2 receptorIBA
04/2023 - 06/2022
2Cholinesterases (Cholinesterase)IBA
12/2022 - 01/2021
2Adenosine (Adenocard)FDA LinkGeneric
11/2022 - 03/2021
2psb-603IBA
11/2022 - 03/2021
2Adenosine A2B ReceptorIBA
11/2022 - 03/2021
2Triglycerides (Triacylglycerol)IBA
06/2022 - 10/2016
2ZymosanIBA
03/2021 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
03/2021 - 01/2021
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 01/2016
2Haloperidol (Haldol)FDA LinkGeneric
05/2020 - 01/2015
2Serotonin ReceptorsIBA
12/2019 - 07/2019
2Ethanol (Ethyl Alcohol)IBA
01/2019 - 11/2015
2Donepezil (Aricept)FDA LinkGeneric
01/2018 - 01/2017
2Cytochrome P-450 CYP3AIBA
01/2018 - 08/2014
2barium chloride (barium dichloride)IBA
04/2012 - 12/2004
2Epinephrine (Adrenaline)FDA LinkGeneric
04/2012 - 12/2004
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2024
1resolvin D2IBA
03/2024
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2024
1sigma Receptors (sigma Receptor)IBA
10/2023
1AntipruriticsIBA
10/2023
1N-dodecyl-L-lysine amideIBA
09/2023
1CannabinoidsIBA
05/2023
1Chloroquine (Aralen)FDA LinkGeneric
05/2023
1FlavonoidsIBA
02/2023
1Sigma-1 ReceptorIBA
01/2023
1piperidineIBA
01/2023
1benzophenoneIBA
12/2022
1Theophylline (Theon)FDA LinkGeneric
11/2022
1ChalconesIBA
07/2022

Therapy/Procedure

6Therapeutics
12/2022 - 01/2018